M Cella1, M G Farina, A P Dominguez Rubio, G Di Girolamo, M L Ribeiro, A M Franchi. 1. Laboratory of Physiopathology of Pregnancy and Labor, Center for Pharmacological and Botanical Studies (National Research Council - School of Medicine, University of Buenos Aires), Buenos Aires, Argentina. makicella@yahoo.com
Abstract
BACKGROUND AND PURPOSE: Maternal infections are one of the main causes of adverse developmental outcomes including embryonic resorption and preterm labour. In this study a mouse model of inflammation-associated preterm delivery was developed, and used to study the relationship between nitric oxide (NO) and prostaglandins (PGs). EXPERIMENTAL APPROACH: The murine model of preterm labour was achieved by assaying different doses of bacterial lipopolysaccharides (LPS). Once established, it was used to analyse uterine levels of prostaglandins E(2) and F(2α) (by radioimmunoassay), cyclooxygenases (COX) and NOS proteins (by Western blot) and NO synthase (NOS) activity. Effects of inhibitors of COX and NOS on LPS-induced preterm labour were also studied. In vitro assays with a nitric oxide donor (SNAP) were performed to analyse the modulation of prostaglandin production by NO. KEY RESULTS: Lipopolysaccharide increased uterine NO and PG synthesis and induced preterm delivery. Co-administration of meloxicam, a cyclooxygenase-2 inhibitor, or aminoguanidine, an inducible NOS inhibitor, prevented LPS-induced preterm delivery and blocked the increase in PGs and NO. Notably, the levels of NO were found to determine its effect on PG synthesis; low concentrations of NO reduced PG synthesis whereas high concentrations augmented them. CONCLUSIONS AND IMPLICATIONS: An infection-associated model of preterm labour showed that preterm delivery can be prevented by decreasing PG or NO production. NO was found to have a dual effect on PG synthesis depending on its concentration. These data contribute to the understanding of the interaction between NO and PGs in pregnancy and parturition, and could help to improve neonatal outcomes.
BACKGROUND AND PURPOSE:Maternal infections are one of the main causes of adverse developmental outcomes including embryonic resorption and preterm labour. In this study a mouse model of inflammation-associated preterm delivery was developed, and used to study the relationship between nitric oxide (NO) and prostaglandins (PGs). EXPERIMENTAL APPROACH: The murine model of preterm labour was achieved by assaying different doses of bacterial lipopolysaccharides (LPS). Once established, it was used to analyse uterine levels of prostaglandins E(2) and F(2α) (by radioimmunoassay), cyclooxygenases (COX) and NOS proteins (by Western blot) and NO synthase (NOS) activity. Effects of inhibitors of COX and NOS on LPS-induced preterm labour were also studied. In vitro assays with a nitric oxidedonor (SNAP) were performed to analyse the modulation of prostaglandin production by NO. KEY RESULTS:Lipopolysaccharide increased uterine NO and PG synthesis and induced preterm delivery. Co-administration of meloxicam, a cyclooxygenase-2 inhibitor, or aminoguanidine, an inducible NOS inhibitor, prevented LPS-induced preterm delivery and blocked the increase in PGs and NO. Notably, the levels of NO were found to determine its effect on PG synthesis; low concentrations of NO reduced PG synthesis whereas high concentrations augmented them. CONCLUSIONS AND IMPLICATIONS: An infection-associated model of preterm labour showed that preterm delivery can be prevented by decreasing PG or NO production. NO was found to have a dual effect on PG synthesis depending on its concentration. These data contribute to the understanding of the interaction between NO and PGs in pregnancy and parturition, and could help to improve neonatal outcomes.
Authors: R Romero; M Sirtori; E Oyarzun; C Avila; M Mazor; R Callahan; V Sabo; A P Athanassiadis; J C Hobbins Journal: Am J Obstet Gynecol Date: 1989-09 Impact factor: 8.661
Authors: M Farina; M L Ribeiro; C Weissmann; A Estevez; S Billi; C Vercelli; A Franchi Journal: J Steroid Biochem Mol Biol Date: 2004-08 Impact factor: 4.292
Authors: María Victoria Bariani; Fernando Correa; Emma Leishman; Ana Paula Domínguez Rubio; Andreína Arias; Aníbal Stern; Heather B Bradshaw; Ana María Franchi Journal: Mol Hum Reprod Date: 2017-08-01 Impact factor: 4.025
Authors: Lynne Sykes; Bronwen R Herbert; David A Macintyre; Emma Hunte; Sathana Ponnampalam; Mark R Johnson; Tiong G Teoh; Phillip R Bennett Journal: Immunology Date: 2013-07 Impact factor: 7.397
Authors: Manuel L Wolfson; Fernando Correa; Emma Leishman; Claudia Vercelli; Cora Cymeryng; Julieta Blanco; Heather B Bradshaw; Ana María Franchi Journal: Mol Cell Endocrinol Date: 2015-05-06 Impact factor: 4.102